SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $619,000 | +58.7% | 39,695 | -3.9% | 0.00% | +100.0% |
| Q3 2020 | $390,000 | +4.6% | 41,316 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $373,000 | +71.1% | 41,589 | +21.5% | 0.00% | 0.0% |
| Q1 2020 | $218,000 | +63.9% | 34,231 | +178.2% | 0.00% | 0.0% |
| Q2 2019 | $133,000 | -7.6% | 12,304 | -18.5% | 0.00% | 0.0% |
| Q1 2019 | $144,000 | -10.6% | 15,089 | +7.4% | 0.00% | 0.0% |
| Q4 2018 | $161,000 | -13.0% | 14,044 | +28.4% | 0.00% | 0.0% |
| Q3 2018 | $185,000 | +29.4% | 10,936 | +8.4% | 0.00% | 0.0% |
| Q2 2018 | $143,000 | -35.3% | 10,093 | -13.3% | 0.00% | 0.0% |
| Q1 2018 | $221,000 | +0.9% | 11,644 | -12.7% | 0.00% | 0.0% |
| Q4 2017 | $219,000 | +19.7% | 13,339 | +9.5% | 0.00% | 0.0% |
| Q3 2017 | $183,000 | +69.4% | 12,181 | -0.9% | 0.00% | 0.0% |
| Q2 2017 | $108,000 | – | 12,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |